GPs ‘fed up’ as Shingrix demand outstrips supply

Dr Rod Pearce says GPs are rationing doses, but the Federal Government has denied there is a vaccine shortage.
Rachel Fieldhouse
Shingrix vaccine. Photo: Wikimedia Commons.

GPs say they have not received enough stock of recombinant herpes zoster vaccine Shingrix to meet patient demand after it was listed on the National Immunisation Program this month.

Patients aged 65 and over, immunocompromised adults and Indigenous patients aged 50 and over are eligible for free Shingrix vaccination after it replaced the live-attenuated vaccine Zostavax on the National Immunisation Program (NIP) on 1 November.